INTERNATIONAL PATENT: BISIRNA THERAPEUTICS (SUZHOU) CO., LTD., 倍臻生物技术（苏州）有限公司 FILES APPLICATION FOR "RIBONUCLEIC ACID COMPOUND CAPABLE OF TRIGGERING GENE SILENCING"

Posted On: 2026-02-02

GENEVA, Feb. 2 -- BISIRNA THERAPEUTICS (SUZHOU) CO., LTD. (Unit 401, Building 5, Block B, Phase III, Biomedical Industrial Park, No 99 Jingu RoadSuzhou, Jiangsu 215000), 倍臻生物技术（苏州）有限公司 (中国江苏省苏州市中国(江苏)自由贸易试验区苏州片区苏州工业园区金谷路99号生物医药产业园三期B区5号楼401单元) filed a patent application (PCT/CN2025/110715) for "RIBONUCLEIC ACID COMPOUND C...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BISIRNA THERAPEUTICS (SUZHOU) CO., LTD., 倍臻生物技术（苏州）有限公司 FILES APPLICATION FOR "RIBONUCLEIC ACID COMPOUND CAPABLE OF TRIGGERING GENE SILENCING"